Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person SARS-CoV-2 3CLpro dimer cleaves TAB1

Class:IdReaction:9729704
_displayNameSARS-CoV-2 3CLpro dimer cleaves TAB1
_doReleaseTRUE
_timestamp2022-03-01 03:11:25
authored[InstanceEdit:9729750] Stephan, Ralf, 2021-05-03
catalystActivity[CatalystActivity:9694394] cysteine-type endopeptidase activity of 3CLp dimer [cytosol]
compartment[Compartment:70101] cytosol
created[InstanceEdit:9729750] Stephan, Ralf, 2021-05-03
disease[Disease:9683912] COVID-19
edited[InstanceEdit:9766200] Shamovsky, Veronica, 2022-02-18
input[EntityWithAccessionedSequence:167923] TAB1 [cytosol] [Homo sapiens]
[SimpleEntity:29356] H2O [cytosol]
[SimpleEntity:29356] H2O [cytosol]
isChimericFALSE
literatureReference[LiteratureReference:9729719] SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species
[LiteratureReference:4332321] TAK1, more than just innate immunity
[LiteratureReference:9729746] ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis)
modified[InstanceEdit:9756480] Shamovsky, Veronica, 2021-10-14
[InstanceEdit:9766202] Shamovsky, Veronica, 2022-02-18
[InstanceEdit:9766342] Shamovsky, Veronica, 2022-02-18
[InstanceEdit:9767634] Shamovsky, Veronica, 2022-03-01
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
nameSARS-CoV-2 3CLpro dimer cleaves TAB1
output[EntityWithAccessionedSequence:9729698] TAB1(1-132) [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9729751] TAB1(1-444) [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9729724] TAB1(133-504) [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9729691] TAB1(445-504) [cytosol] [Homo sapiens]
precedingEvent
relatedSpecies[Species:9681683] Severe acute respiratory syndrome coronavirus 2
releaseDate2022-03-23
reviewed[InstanceEdit:9766195] Messina, Francesco, 2022-02-18
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9729756] R-HSA-9729704.2
summation[Summation:9729716] SARS-CoV-2 nsp5 protease (3CLpro) specifically cleaves TAB1 ...
(hasEvent)[Pathway:9705671] SARS-CoV-2 activates/modulates innate and adaptive immune responses [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by SARS-CoV-2 3CLpro dimer cleaves TAB1 (9729704)